Clinical Oncology

Papers
(The TQCC of Clinical Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Supportive Care: An Indispensable Component of Modern Oncology75
Clinical Characteristics and Outcomes in Patients with COVID-19 and Cancer: a Systematic Review and Meta-analysis61
Machine Learning for Auto-Segmentation in Radiotherapy Planning60
UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy54
Eliminating Cervical Cancer: Progress and Challenges for High-income Countries39
Image-guided Radiotherapy to Manage Respiratory Motion: Lung and Liver37
Overall Survival Prognostic Modelling of Non-small Cell Lung Cancer Patients Using Positron Emission Tomography/Computed Tomography Harmonised Radiomics Features: The Quest for the Optimal Machine Lea36
Can Rational Combination of Ultra-high Dose Rate FLASH Radiotherapy with Immunotherapy Provide a Novel Approach to Cancer Treatment?35
Adaptive Radiotherapy in the Management of Cervical Cancer: Review of Strategies and Clinical Implementation34
Image-guided Adaptive Radiotherapy for Bladder Cancer33
Stereotactic Radiosurgery and Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease32
Deep Learning for Radiotherapy Outcome Prediction Using Dose Data – A Review31
The Financial Impact on Reimbursement of Moderately Hypofractionated Postoperative Radiation Therapy for Breast Cancer: An International Consortium Report30
Image-Guided Radiotherapy for Pelvic Cancers: A Review of Current Evidence and Clinical Utilisation29
Five-fraction Radiotherapy for Breast Cancer: FAST-Forward to Implementation27
Incidence, Treatment and Outcomes of Cervical Cancer in Low- and Middle-income Countries24
The Routine Clinical Implementation of Electronic Patient-reported Outcome Measures (ePROMs) at The Christie NHS Foundation Trust24
Rapid Access Palliative Radiotherapy Programmes24
Structure and Processes of Existing Practice in Radiotherapy Peer Review: A Systematic Review of the Literature22
Moving Forward Fast with FAST-Forward22
A Review of the Metrics Used to Assess Auto-Contouring Systems in Radiotherapy22
How Low Can You Go? The Radiobiology of Hypofractionation21
Neoadjuvant Radiotherapy Dose Escalation in Locally Advanced Rectal Cancer: a Systematic Review and Meta-analysis of Modern Treatment Approaches and Outcomes21
Radiomics for Predicting Lung Cancer Outcomes Following Radiotherapy: A Systematic Review21
Improving the Quality of Care in Radiation Oncology using Artificial Intelligence20
Model-Based Selection for Proton Therapy in Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences20
Laparoscopic and Robotic Surgery for Endometrial and Cervical Cancer20
A Novel Model and Infrastructure for Clinical Outcomes Data Collection and Their Systematic Evaluation for UK Patients Receiving Proton Beam Therapy20
Stereotactic Body Radiation Therapy in the Management of Oligometastatic and Oligoprogressive Bladder Cancer and Other Urothelial Malignancies20
Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III19
Advances in External Beam Radiation Therapy and Brachytherapy for Cervical Cancer19
Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 202018
Body Composition and Dose-limiting Toxicity in Colorectal Cancer Chemotherapy Treatment; a Systematic Review of the Literature. Could Muscle Mass be the New Body Surface Area in Chemotherapy Dosing?17
Current Status and Future Direction of Hepatic Radioembolisation17
Dabrafenib and Trametinib Therapy for Advanced Anaplastic Thyroid Cancer – Real-World Outcomes From UK Centres17
The Metaverse and Oncology16
Radiation-Induced Sarcoma: A Retrospective Population-Based Study Over 34 Years in a Single Institution16
Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up16
Prostate Volume Changes during Extreme and Moderately Hypofractionated Magnetic Resonance Image-guided Radiotherapy16
Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation16
Outcomes of Patients Treated in the UK Proton Overseas Programme: Central Nervous System Group16
The Pivotal Role of the Therapeutic Radiographer/Radiation Therapist in Image-guided Radiotherapy Research and Development15
Hypoxia and its Modification in Bladder Cancer: Current and Future Perspectives15
Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group15
Patient-reported Quality of Life following Stereotactic Body Radiation Therapy for Primary Kidney Cancer – Results from a Prospective Cohort Study15
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma15
Ultrasound-guided Brachytherapy for Cervix Cancer15
Advancing Roles of Healthcare Professionals in Palliative Radiotherapy15
The Development of Therapeutic Radiographers in Imaging and Adaptive Radiotherapy Through Clinical Trial Quality Assurance15
Can Real-world Data and Rapid Learning Drive Improvements in Lung Cancer Survival? The RAPID-RT Study15
Artificial Intelligence for Radiotherapy Auto-Contouring: Current Use, Perceptions of and Barriers to Implementation15
Surveying the Challenges to Improve Linear Accelerator-based Radiation Therapy in Africa: a Unique Collaborative Platform of All 28 African Countries Offering Such Treatment15
Advanced Cancer Patients' Prognostic Awareness and Its Association With Anxiety, Depression and Spiritual Well-Being: A Multi-Country Study in Asia15
Palliative Radiation Therapy in Older Adults With Cancer: Age-Related Considerations15
Utility of Prophylactic Cranial Irradiation for Limited Stage Small Cell Lung Cancer in the Modern Era with Magnetic Resonance Imaging Surveillance14
Therapeutic Modification of Hypoxia14
Does Concurrent Use of CDK4/6 Inhibitors During Palliative Radiotherapy Increase Toxicity in Patients With Metastatic Breast Cancer?14
Neutrophil–Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung Cancer14
Set-Up Errors, Organ Motion, Tumour Regression and its Implications on Internal Target Volume–Planning Target Volume During Cervical Cancer Radiotherapy: Results From a Prospective Study14
Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review14
Global Longitudinal Strain for the Early Detection of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis14
HERMES: Delivery of a Speedy Prostate Cancer Treatment14
Ultrahypofractionated Radiotherapy for Localised Prostate Cancer: How Far Can We Go?14
A Brief Overview of the Preclinical and Clinical Radiobiology of Microbeam Radiotherapy14
Accelerated Adaptation of Ultrahypofractionated Radiation Therapy for Breast Cancer at the Time of the COVID-19 Pandemic14
Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas13
Prospective Longitudinal Assessment of Quality of Life and Activities of Daily Living as Patient-Reported Outcome Measures in Recurrent/Progressive Glioma Treated with High-dose Salvage Re-irradiation13
Gender Differences and Their Effects on Survival Outcomes in Lung Cancer Patients Treated With PD-1/PD-L1 Checkpoint Inhibitors: A Systematic Review and Meta-Analysis13
Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung – The Knockout Punch13
Adjuvant and Neoadjuvant Radiation Therapy for Locally Advanced Bladder Cancer13
Impaired Geriatric 8 Score is Associated with Worse Survival after Radiotherapy in Older Patients with Cancer13
The Changing Landscape for the Treatment of Painful Spinal Metastases: is Stereotactic Body Radiation Therapy the New Standard of Care?12
Comparative Effectiveness Analyses of Salvage Prostatectomy and Salvage Radiotherapy Outcomes Following Focal or Whole-Gland Ablative Therapy (High-Intensity Focused Ultrasound, Cryotherapy or Electro12
Systemic Radiotherapy of Bone Metastases With Radionuclides12
The Association of Incidental Radiation Dose to the Heart Base with Overall Survival and Cardiac Events after Curative-intent Radiotherapy for Non-small Cell Lung Cancer: Results from the NI-HEART Stu12
Moderately Hypofractionated Radiotherapy and Androgen Deprivation Therapy for High-risk Localised Prostate Cancer: Predictors of Long-term Biochemical Control and Toxicity12
The Rise of Supportive Oncology: A Revolution in Cancer Care12
Effect of Race and Ethnicity on Risk of Radiotherapy Toxicity and Implications for Radiogenomics12
Assessing Equity of Access to Proton Beam Therapy: A Literature Review12
Sexual and Psychosexual Consequences of Treatment for Gynaecological Cancers12
Early Mortality after Radical Radiotherapy in Head and Neck Cancer – A Nationwide Analysis from the Danish Head and Neck Cancer Group (DAHANCA) Database12
Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial11
Gastrointestinal Toxicity of Pelvic Radiotherapy: Are We Letting Women Down?11
Recommendations for Multicentre Clinical Trials Involving Dosimetry for Molecular Radiotherapy11
Digital Medicine in Men with Advanced Prostate Cancer – A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment11
Prehabilitation and Rehabilitation for Patients with Lung Cancer: A Review of Where we are Today11
Comparing the Ability of Physician-Reported Versus Patient-Reported Performance Status to Predict Survival in a Population-Based Cohort of Newly Diagnosed Cancer Patients11
Pencil Beam Scanning Proton Therapy Case Selection for Paediatric Abdominal Neuroblastoma: Effects of Tumour Location and Bowel Gas11
Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review11
Multicentre Trials on Standardised Quantitative Imaging and Dosimetry for Radionuclide Therapies11
Spine and Non-spine Bone Metastases – Current Controversies and Future Direction11
Postmastectomy Radiation Therapy Planning After Immediate Implant-based Reconstruction Using the European Society for Radiotherapy and Oncology-Advisory Committee in Radiation Oncology Practice Consen11
A Multicentre UK Study of Outcomes for Locally Advanced Sinonasal Squamous Cell Carcinoma Treated with Adjuvant or Definitive Intensity-modulated Radiotherapy11
Sacral Insufficiency Fracture Following Pelvic Radiotherapy in Gynaecological Malignancies: Development of a Predictive Model11
Functional Imaging to Predict Treatment Response in Head and Neck Cancer: How Close are We to Biologically Adaptive Radiotherapy?11
Combining External Beam Radiation and Radionuclide Therapies: Rationale, Radiobiology, Results and Roadblocks11
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years10
Complex Clinical Decision-Making Process of Re-Irradiation10
Implementation of Royal College of Radiologists Consensus Statements and National Institute for Health and Care Excellence Guidance: Breast Radiotherapy Practice in the UK10
Validation of a Fully Automated Hybrid Deep Learning Cardiac Substructure Segmentation Tool for Contouring and Dose Evaluation in Lung Cancer Radiotherapy10
Safe and Ethical Artificial Intelligence in Radiotherapy – Lessons Learned From the Aviation Industry10
Evaluation of Prognostic and Predictive Models in the Oncology Clinic10
Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes10
Liver Immune-related Adverse Effects of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Inhibitors: A Propensity Score Matched Study with Competing Risk Analyses9
The National Lung Cancer Audit: The Impact of COVID-199
Late Toxicity and Long-Term Local Control in Patients With Ultra-Central Lung Tumours Treated by Intensity-Modulated Radiotherapy-Based Stereotactic Ablative Body Radiotherapy With Homogenous Dose Pre9
On Target 2: Updated Guidance for Image-guided Radiotherapy9
SCOPE 2 – Still Answering the Unanswered Questions in Oesophageal Radiotherapy? SCOPE 2: a Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients with Oesophageal Cancer Treat9
Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER)9
Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?9
Is There a Benefit of Combining Immunotherapy and Radiotherapy in Bladder Cancer?9
A Predictive Model for Reactive Tube Feeding in Head and Neck Cancer Patients Undergoing Definitive (Chemo) Radiotherapy9
Estimating the Risk of Death from COVID-19 in Adult Cancer Patients9
What Really Matters for Cancer Care – Health Systems Strengthening or Technological Innovation?9
Safety and Efficacy of Ultra-hypofractionation in Node-positive Prostate Cancer9
Scientific Developments in Imaging and Dosimetry for Molecular Radiotherapy9
Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiation Therapy Compared With Surgery and Radiofrequency Ablation in Two Patient Cohorts: Metastatic Liver Cancer and Hepatocellular Carcino9
How Useful is COVID-19 Antibody Testing – A Current Assessment for Oncologists9
Impact of Concomitant Medications on Biochemical Outcome in Localised Prostate Cancer Treated with Radiotherapy and Androgen Deprivation Therapy9
Early Diagnosis and Lung Cancer Screening9
Education to Improve Cancer Care for LGBTQ+ Patients in the UK9
Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO Study9
Predicting the Risk of Disease Recurrence and Death Following Curative-intent Radiotherapy for Non-small Cell Lung Cancer: The Development and Validation of Two Scoring Systems From a Large Multicentr8
From 25 Fractions to Five: How Hypofractionation has Revolutionised Adjuvant Breast Radiotherapy8
Repurposing Radiation Therapy for Immuno-oncology8
Adjuvant Therapy for High-risk Endometrial Carcinoma8
Long-term Survival Outcomes of ‘Low Risk’ Ductal Carcinoma in situ from a Territory-wide Cancer Registry8
Combined Radiotherapy and New Systemic Therapies – Have We Moved Beyond Palliation?8
Identifying Risk Factors for Anthracycline Chemotherapy-induced Phlebitis in Women with Breast Cancer: An Observational Study8
Effect of Neoadjuvant Therapy on the Functional Outcome of Patients With Rectal Cancer: A Systematic Review and Meta-Analysis8
The Cost-effectiveness of Watch and Wait for Rectal Cancer8
Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease8
Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial8
Peptide Receptor Radionuclide Therapy – Prospects for Personalised Treatment8
Feasibility of Proton Beam Therapy for Infants with Brain Tumours: Experiences from the Prospective KiProReg Registry Study8
Surgical and Radiotherapeutic Management of Malignant Extradural Spinal Cord Compression8
Innovative Follow-up Strategies for Endometrial Cancer7
Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy7
Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces7
Audit of Molecular Mechanisms of Primary and Secondary Resistance to Various Generations of Tyrosine Kinase Inhibitors in Known Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Cancer Patie7
Clinical Outcome of Sacral Chordoma Patients Treated with Pencil Beam Scanning Proton Therapy7
Developing UK Guidance on How Long Men Should Abstain from Receiving Anal Sex before, During and after Interventions for Prostate Cancer7
Imaging of Neck Nodes in Head and Neck Cancers – a Comprehensive Update7
Leveraging Radiobiology for Arrhythmia Management: A New Treatment Paradigm?7
Paediatric Molecular Radiotherapy: Challenges and Opportunities7
Nomogram Based on Clinical and Radiomics Data for Predicting Radiation-induced Temporal Lobe Injury in Patients with Non-metastatic Stage T4 Nasopharyngeal Carcinoma7
Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response7
A Prospective Study of Diffusion-weighted Magnetic Resonance Imaging as an Early Prognostic Biomarker in Chemoradiotherapy in Squamous Cell Carcinomas of the Anus7
The Practice of Paediatric Radiation Oncology in Low- and Middle-income Countries: Outcomes of an International Atomic Energy Agency Study7
Modern Tools for Modern Brachytherapy7
Understanding Survival Analysis in Clinical Trials7
Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK7
COVID RT – Assessing the Impact of COVID-19 on Radiotherapy in the UK. A National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Initiative in Partnership wit7
The Potential Impact and Usability of the Eighth Edition TNM Staging Classification in Oral Cavity Cancer7
Overcoming Osimertinib Resistance in Advanced Non-small Cell Lung Cancer7
Imaging Analytics using Artificial Intelligence in Oncology: A Comprehensive Review7
Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: an Updated Systematic Review7
Surgical Treatments of Benign Prostatic Hyperplasia and Prostate Cancer Stereotactic Radiotherapy: Impact on Long-Term Genitourinary Toxicity7
A Short Report Examining the Introduction of Routine Use of Patient-Reported Outcome Measures in a Mixed Oncology Population7
Platinum-Based Chemotherapy ‘Rechallenge’ in Advanced Non-ovarian Solid Malignancies6
Change in the Use of Fractionation in Radiotherapy Used for Early Breast Cancer at the Start of the COVID-19 Pandemic: A Population-Based Cohort Study of Older Women in England and Wales6
Patient-centered Outcomes in Breast Cancer: Description of EQ-5D-5L and EORTC-QLQ-BR23 Measurements in Real-world Data and Their Association With Survival6
Does Loosening the Inclusion Criteria of the CROSS Trial Impact Outcomes in the Curative-Intent Trimodality Treatment of Oesophageal and Gastroesophageal Cancer Patients?6
Nurturing a Research-active Clinical Oncology Workforce: A Trainee Perspective6
What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist?6
Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era — The Early and Late Effects of Radiation and Cisplatin6
Risk-group Classification by Recursive Partitioning Analysis of Patients Affected by Oligometastatic Renal Cancer Treated with Stereotactic Radiotherapy6
Notch Inhibition: a Promising Strategy to Improve Radiosensitivity and Curability of Radiotherapy6
Beyond Teenage and Young Adult Cancer Care: Care Experiences of Patients Aged 25–39 Years Old in the UK National Health Service6
Advances in Skin Brachytherapy: Cosmesis and Function Preservation6
Presentation, Diagnosis and Treatment Delays in Breast Cancer Care and Their Associations in Sri Lanka, a Low-resourced Country6
Is the Management of Rectal Cancer Using a Watch and Wait Approach Feasible, Safe and Effective in a Publicly Funded General Hospital?6
Optimal Timing for COVID-19 Vaccination in Oncology Patients Receiving Chemotherapy?6
Review of Conventional and High Dose Rate Brain Radiation (FLASH): Neurobehavioural, Neurocognitive and Assessment Issues in Rodent Models6
Impact of Adjuvant Treatment in pN3 Penile Cancer6
Registries, Databases and Repositories for Developing Artificial Intelligence in Cancer Care6
The Incidence and Prognosis Value of Perineural Invasion in Rectal Carcinoma: From Meta-Analyses and Real-World Clinical Pathological Features6
RADICALS-HD: Reflections before the Results are Known6
Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage Lung Cancer – A Done Deal?6
Evaluation of the Impact of Magnetic Resonance Imaging with Susceptibility-weighted Imaging for Screening and Surveillance of Radiation-induced Cavernomas in Long-term Survivors of Malignancy6
Failing to Close the Gap Between Evidence and Clinical Practice in Radical Bladder Cancer Radiotherapy6
High Dose Rate Brachytherapy for Inoperable Endometrial Cancer: a Case Series and Systematic Review of the Literature6
Immunotherapy and Systemic Therapy in Metastatic/Recurrent Endometrial and Cervical Cancers6
A Multicentre Clinical Study of Sarcoma Personalised Treatment Using Patient-Derived Tumour Xenografts5
Current Status of Anatomical Magnetic Resonance Imaging in Brachytherapy and External Beam Radiotherapy Planning and Delivery5
Using Real-world Data to Define a Validated Nomogram for Advanced Bladder Cancer Patients Who Respond to Immunotherapy5
SARS-CoV-2 Infection and Antibody Seroprevalence among UK Healthcare Professionals Working with Cancer Patients during the First Wave of the COVID-19 Pandemic5
Hypofractionation in Hepatocellular Carcinoma – The Effect of Fractionation Size5
COVID-19 Serology in Oncology Staff Study: Understanding SARS-CoV-2 in the Oncology Workforce5
Prediction of Radiation-induced Lymphopenia following Exposure of the Thoracic Region and Associated Risk of Infections and Mortality5
A Meta-analysis of the Efficacy and Safety of Stereotactic Arrhythmia Radioablation (STAR) in Patients with Refractory Ventricular Tachycardia5
Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung Cancer5
Radiosensitivity Index is Not Fit to be Used for Dose Adjustments: A Pan-Cancer Analysis5
Challenges in the Sustainability of Brachytherapy Service in Contemporary Radiotherapy5
Patient Preparation and Radiation Protection Guidance for Adult Patients Undergoing Radioiodine Treatment for Thyroid Cancer in the UK5
Potential for Isotoxic Re-irradiation Stereotactic Ablative Body Radiotherapy in Locally Recurrent Rectal Cancer5
The Effect of Breast Cancer Subtype on Symptom Improvement Following Palliative Radiotherapy for Bone Metastases5
Variations in Demand across England for the Magnetic Resonance-Linac Technology, Simulated Utilising Local-level Demographic and Cancer Data in the Malthus Project5
Evaluation of Ultra-low-dose Paediatric Cone-beam Computed Tomography for Image-guided Radiotherapy5
Analysis of the Safety and Pregnancy Outcomes of Fertility-sparing Surgery in Ovarian Malignant Sex Cord-stromal Tumours: A Multicentre Retrospective Study5
The Impact of COVID-19 on Radiotherapy Services in Scotland, UK: A Population-based Study5
Health Economic and Health Service Issues of Palliative Radiotherapy5
Fertility Preservation in Female Patients with Cancer5
An Overview of the Role of Radiotherapy in the Treatment of Small Cell Lung Cancer – A Mainstay of Treatment or a Modality in Decline?5
The Effect of Renin–Angiotensin–Aldosterone System Inhibitors on Outcomes of Patients Treated with Immune Checkpoint Inhibitors: a Retrospective Cohort Study5
Technical Radiotherapy Advances – The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of Hypofractionation5
Effect of PD-L1 Expression for the PD-1/L1 Inhibitors on Non-small Cell Lung Cancer: A Meta-analysis Based on Randomised Controlled Trials5
Computed Tomography Radiomics to Differentiate Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma5
The Importance of Tackling the Social Determinants of Health to Address the Unmet Need within Cancer Services. Reflections from Build Back Fairer: the COVID-19 Marmot Review5
The Long and the Short of it: the Role of Short-course Radiotherapy in the Neoadjuvant Management of Rectal Cancer5
Delivery Models and Health Economics of Supportive Care Services in England: A Multicentre Analysis5
A New Approach to Quantify and Grade Radiation Dermatitis Using Deep-Learning Segmentation in Skin Photographs5
Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?5
BONUS: the National Oncology Network for Students and Junior Doctors5
The Association of Clinical Characteristics and Tumour Markers With Image-Defined Risk Factors in the Management of Neuroblastoma in South Africa5
Dosimetric and Clinical Predictors for Acute and Late Gastrointestinal Toxicity Following Chemoradiotherapy of Locally Advanced Anal Cancer5
Assessing Bladder Radiotherapy Response With Quantitative Diffusion-Weighted Magnetic Resonance Imaging Analysis5
When Less is More: The Rising Tide of Hypofractionation5
Clinical Predictors of Response to Anti-PD-1 First-Line Treatment in a Single-Centre Patient Cohort: A Real-World Study5
Target Volume Coverage and Organ at Risk Doses for Left-sided Whole-breast Irradiation With or Without Internal Mammary Chain Irradiation: A Comparison Between Three Techniques Representing the Past a5
Survival Outcomes Following Discontinuation of Ipilimumab and Nivolumab for Advanced Melanoma in a Population-based Cohort5
The Pattern of Care of Use of Nivolumab in Head and Neck Cancers – Audit From a Tertiary Cancer Centre5
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis5
Medical Student Perspectives on Undergraduate Oncology Education in the UK5
Proton Beam Therapy in Breast Cancer Patients: The UK PARABLE Trial is Recruiting5
Global Health System Resilience during Encounters with Stressors – Lessons Learnt from Cancer Services during the COVID-19 Pandemic5
Deep-learning Method for the Prediction of Three-Dimensional Dose Distribution for Left Breast Cancer Conformal Radiation Therapy5
Embracing Skill Mix in the Clinical Oncology Workforce – Capturing Impacts of Consultant Therapeutic Radiographers in the UK5
Nature Versus Nurture: What Underpins Great Leadership? The Case for Nurture4
The Use of Palliative Radiotherapy in the Treatment of Lung Cancer4
External Beam Radiotherapy in Western Africa: 1969–20194
Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free Survival4
Effectiveness of Trastuzumab in Routine Clinical Practice: A Population-based Study of Patients with HER-2-positive Oesophageal, Gastroesophageal and Gastric Cancer4
Pharyngeal Constrictor Dose–Volume Histogram Metrics and Patient-Reported Dysphagia in Head and Neck Radiotherapy4
The Management of Oligometastases in Non-small Cell Lung Cancer – is Stereotactic Ablative Radiotherapy now Standard of Care?4
Patient-reported Experience Measure for Neuro-oncology Telephone Clinics during the COVID-19 Pandemic4
Mapping Local Failure Following Bladder Radiotherapy According to Dose4
Hidden in Plain Sight: Clinical Informaticians are the Oncology Subspecialists You Did Not Know You Needed4
Thirty-Day Mortality Following Systemic Anticancer Therapy: Evaluating Risk Factors Without Selection Bias in a Real-World, Population-Based Cohort From 2009 to 20194
Daily Adaptive Radiotherapy Using the Varian ETHOS System to Improve Dose Distribution During Treatment to the Upper Abdomen4
Locoregional control and toxicity following high-dose hypofractionated and accelerated palliative radiotherapy regimens in breast cancer4
First-line Cemiplimab versus Standard Chemotherapy in Advanced Non-small Cell Lung Cancer Patients with at Least 50% Programmed Cell Death Receptor Ligand-1 Positivity: Analysis of Cost-effectiveness4
Geometric and Dosimetric Evaluation of a Commercially Available Auto-segmentation Tool for Gross Tumour Volume Delineation in Locally Advanced Non-small Cell Lung Cancer: a Feasibility Study4
Electronic Patient-Reported Outcome Measures for Monitoring of Patients on Cancer Treatment Can Reduce the Need for Face-To-Face Hospital Visits: A Tertiary UK Oncology Centre Experience4
Radiotherapy for Oropharyngeal Carcinoma With an Uninvolved Contralateral Neck: The Safety of Omission of Contralateral High Level II and Retropharyngeal Lymph Nodes From Elective Target Volumes4
Implementing Genomic Testing for Lung Cancer Into Routine Clinical Practice – The Welsh Experience4
Does Mastectomy Reduce Overall Survival in Early Stage Breast Cancer?4
Creating a Sustainable Future of Radiotherapy Following COP26: A Case for Lung Stereotactic Ablative Radiotherapy Over Surgery?4
Relationship of Urethral Dose and Genitourinary Toxicity Among Patients Receiving Vaginal High Dose Rate Interstitial Brachytherapy4
Patient-Reported Outcomes and Health-Related Quality of Life Following Radiotherapy for Bladder Cancer4
0.043200969696045